Carcinoid & Neuroendocrine Cancer Educational Event
28 February 2017
Multiple, Gilbert, Phoenix, Tucson, Internet, United States
Hosted by Arizona Carcinoid & Neuroendocrine Foundation, Inc.
The Arizona Carcinoid & Neuroendocrine Cancer Foundation, Inc. is collaborating with Banner/MD Anderson and the Arizona Telemedicine Program to present an educational event on Rare Disease Day about this rare cancer. On February 28, 2017 from 10 am to 2 pm MST, clinicians and other health professionals, health profession students, and patients/caregivers/community members are invited to attend as a panel of experts presents an overview of carcinoid and neuroendocrine cancer. Panelists include medical oncologists, surgical oncologists, radiologists and others who specialize in carcinoid and neuroendocrine cancer. Panelists will discuss details of this rare disease--current surveillance, diagnostic and treatment modalities, and new and upcoming surveillance, diagnostic and treatment modalities.
In-person attendees will be welcomed at Banner/MD Anderson in Gilbert, at the University of Arizona College of Medicine/Phoenix or the University of Arizona College of Nursing/Tucson. Internet viewing of the event is also available through the Arizona Telemedicine Program. Registration is available at https://www.surveymonkey.com/r/neuroendocrinecancer
Carcinoid and neuroendocrine tumors (NETs) begin in the neuroendocrine cells, which are distributed widely throughout the body. They commonly first appear in the gastrointestinal tract (e.g. stomach, pancreas, appendix, intestines, etc.) but can also be found in, and frequently metastasize to, other parts of the body, including the breast, heart, lungs, thymus, liver, pancreas as well as other organs. The constellation of symptoms (e.g. flushing, diarrhea, asthma, congestive heart failure, abdominal cramping, high blood pressure and peripheral edema) can result in acute care/emergency visits of increasing frequency.